Cargando…

The Effect of Bevacizumab on Corneal Neovascularization in Rabbits

PURPOSE: To determine the efficacy of topical application and subconjunctival injection of bevacizumab in the treatment of corneal neovascularization. METHODS: Corneal neovascularization was induced with a silk suture of the corneal stroma in 12 rabbits (24 eyes). One week after suturing, four rabbi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Wung-Jae, Jeong, Hee-Ok, Chung, Sung-Kun
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Ophthalmological Society 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916105/ https://www.ncbi.nlm.nih.gov/pubmed/20714387 http://dx.doi.org/10.3341/kjo.2010.24.4.230

Ejemplares similares

Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
por: Ahn, Ye Jin, et al.
Publicado: (2014)

The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model
por: Mello, Glauco Reggiani, et al.
Publicado: (2011)

Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
por: Britton, Anna Krystyna, et al.
Publicado: (2020)

The Effect of Bevacizumab versus Ranibizumab in the Treatment of Corneal Neovascularization: A Preliminary Study
por: Kim, Jin-Hyoung, et al.
Publicado: (2013)

Topical Timolol Inhibits Corneal Neovascularization in Rabbits
por: KASIRI, Ali, et al.
Publicado: (2017)

Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
por: Krizova, Deli, et al.
Publicado: (2014)

Mechanisms Controlling the Effects of Bevacizumab (Avastin) on the Inhibition of Early but Not Late Formed Corneal Neovascularization
por: Chen, Wei-Li, et al.
Publicado: (2014)

Prevention of Corneal Neovascularization; a Preliminary Experimental Study in Rabbits
por: Kasiri, Ali, et al.
Publicado: (2020)

Triamcinolone Acetonide as an Adjunct to Bevacizumab for Prevention of Corneal Neovascularization in a Rat Model
por: Mehrjardi, Hadi Z., et al.
Publicado: (2014)

Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes
por: Sarah, Belghmaidi, et al.
Publicado: (2016)

Comparison of different doses of subconjunctival sunitinib with bevacizumab in the treatment of corneal neovascularization in experimental rats
por: Hashemian, Mohammad Nasser, et al.
Publicado: (2017)

Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma
por: Ha, Jun Young, et al.
Publicado: (2017)

Comparison of the Therapeutic Efficacies of Topical Rivoceranib and Topical Bevacizumab in a Murine Model of Corneal Neovascularization
por: Yoon, Hyeon Jeong, et al.
Publicado: (2019)

Effects of VEGF Inhibitor Conbercept on Corneal Neovascularization Following Penetrating Keratoplasty in Rabbit Model
por: Liu, Huan, et al.
Publicado: (2020)

Effect of Collagen Cross-Linking on Alkali Burn-Induced Corneal Neovascularization in Rabbits
por: Xu, Xiaoying, et al.
Publicado: (2018)

Photo-Mediated Ultrasound Therapy for the Treatment of Corneal Neovascularization in Rabbit Eyes
por: Qin, Yu, et al.
Publicado: (2020)

The therapeutic effect of bevacizumab on plaque neovascularization in a rabbit model of atherosclerosis during contrast-enhanced ultrasonography
por: Li, Yang, et al.
Publicado: (2016)

Safety of Bevacizumab on Extraocular Muscle in a Rabbit Model
por: Jung, Jae Ho, et al.
Publicado: (2012)

Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization
por: Dratviman-Storobinsky, Olga, et al.
Publicado: (2009)

Successful regression of newly formed corneal neovascularization by subconjunctival injection of bevacizumab in patients with chemical burns
por: Peng, Wen-yan, et al.
Publicado: (2023)

The Antiangiogenic Properties of Adipose-Derived Mesenchymal Stem/Stromal Cells in Corneal Neovascularization in a Rabbit Model
por: Pirounides, Demetrios, et al.
Publicado: (2020)

Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab
por: Anand, Nandita, et al.
Publicado: (2019)

Bevacizumab (Avastin(®)) for the management of anterior chamber neovascularization and neovascular glaucoma
por: Brouzas, Dimitrios, et al.
Publicado: (2009)

Inhibited corneal neovascularization in rabbits following corneal alkali burn by double-target interference for VEGF and HIF-1α
por: Fu, Ying-Cong, et al.
Publicado: (2019)

Corneal neovascularization: An enigma
por: Gupta, Pulkit, et al.
Publicado: (2013)

Study of the Effect of Injection Bevacizumab through Various Routes in Neovascular Glaucoma
por: Bhagat, Purvi R, et al.
Publicado: (2016)

Impaired Autophagy Causes Severe Corneal Neovascularization
por: Yi, Kun, et al.
Publicado: (2022)

Establishment of the New Zealand white rabbit animal model of fatty keratopathy associated with corneal neovascularization
por: Gao, Yikui, et al.
Publicado: (2021)

Photodynamic Therapy with Verteporfin for Corneal Neovascularization
por: Al-Torbak, Abdullah A.
Publicado: (2012)

Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case report
por: Iannetti, Ludovico, et al.
Publicado: (2013)

Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts
por: Lee, Seung Hoon, et al.
Publicado: (2016)

Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration
por: Riazi-Esfahani, Mohammad, et al.
Publicado: (2008)

Effect of Preoperative Intravitreal Bevacizumab on the Surgical Outcome of Neovascular Glaucoma at Different Stages
por: Kwon, Junki, et al.
Publicado: (2017)

Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization
por: Al-Debasi, Tariq, et al.
Publicado: (2017)

Corneal neovascularization and biological therapy
por: Voiculescu, OB, et al.
Publicado: (2015)

Antiangiogenic effects of catalpol on rat corneal neovascularization
por: Han, Yun, et al.
Publicado: (2018)

Combined Treatment of Photodynamic Therapy and Bevacizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
por: Kim, Hyun Woong, et al.
Publicado: (2011)

The use of aflibercept (VEGF trap) in mitigating sulfur mustard-induced corneal neovascularization in a rabbit model
por: Gore, Ariel, et al.
Publicado: (2023)

Regression of Iris Neovascularization after Subconjunctival Injection of Bevacizumab
por: Ryoo, Na Kyung, et al.
Publicado: (2013)

Intravitreal Bevacizumab as a Primary Treatment for Idiopathic Choroidal Neovascularization
por: Cheema, Rizwan A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_26tr89vlo9lgqo88bqd8vnrhmh